PDGFRB and breast cancer: Mechta-Grigoriou et al. characterized four CAF subsets in breast, ovarian cancers and metastatic lymph node of breast cancer with distinct properties by analyzing six fibroblast biomarkers (FAP, α-SMA, β1/CD29, S100A4, PDGFRβ, and CAV1).